ACTIVE SUBSTANCE / INN

CEFEPIME HYDROCHLORIDE

Brand name(s): CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE, CEFEPIME IN PLASTIC CONTAINER, EXBLIFEP, CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER, MAXIPIME
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA050679
ANDA209408
ACTIVE SUBSTANCE
Cefepime Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
SAMSON MEDCL, SAGENT PHARMS INC, BAXTER HLTHCARE
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CEFEPIME HYDROCHLORIDEANDA202268HOSPIRA INCDiscontinued
CEFEPIME IN PLASTIC CONTAINERNDA050817BAXTER HLTHCAREPrescription
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINERANDA209408SAMSON MEDCLPrescription
EXBLIFEPNDA216165ORCHID PHARMADiscontinued
CEFEPIME HYDROCHLORIDEANDA091048SAGENT PHARMS INCPrescription
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINERNDA050821B BRAUNPrescription
MAXIPIMENDA050679HOSPIRA INCDiscontinued

FULL INTELLIGENCE ON CEFEPIME HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →